About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT05812209

Stellate Ganglion Block to Treat Long COVID 19 Case Series

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Lead sponsor: Metamorphosis LTD•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Metamorphosis LTD

We evaluated the treatment results of 41 patients (18 male and 23 female) aged between 18 and 89, who received Stellate Ganglion Block (SGB) with Ultrasound guidance for Long COVID-19 Syndrome. The patients were from the United States and received treatment at our Colorado clinics during the period of September to December 2022.Those who responded to our post-procedure follow-up calls were included in the study population.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\-

Exclusion Criteria

•Stellate Ganglion Block Contraindications
•\-

Related studies

RECRUITINGPhase 3

Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID

NCT06631287 · Long COVID, Sars-CoV-2 Infection, and more

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

NCT06871293 · Long COVID-19 Syndrome, COVID 19, and more

Long COVID Brain Fog: Cognitive Rehabilitation Trial

NCT06095297 · Long COVID, Brain Fog, and more

Immune-mediated Pathogenic Mechanisms of Neuro-PASC in Veterans

NCT06932237 · Neuro-PASC, Long COVID

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

NCT06082518 · Post COVID-19 Condition, Post-COVID-19 Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 13, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment41

Start dateSep 2022

Last updatedApr 13, 2023

Condition

Long COVID Long Covid19 Post-COVID-19 Syndrome Post Acute COVID-19 Syndrome Dysautonomia+10 more

Locations shown

Metamorphosis LTD

Cañon City, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2023Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions